News
Titan Pharmaceuticals
TTNP · NASDAQ
$4.61−$0.18 (−3.76%)TodayMarket closed ·
No price history for this range.
Latest news
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseBusiness Wire
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, SPTN, TTNP on Behalf of Shareholders
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of TTNP, BASE, SPTN, and CFSB
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TCBC, CIO, TTNP, and VBTX
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseGlobe Newswire
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders
- Press releaseGlobe Newswire
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsRishabh Mishra
US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted'
- NewsAvi Kapoor
Goldman Sachs, M&T Bank And 3 Stocks To Watch Heading Into Monday
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
- Press releaseGlobe Newswire
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, PWUP, DECA, TTNP on Behalf of Shareholders
- Press releasePRNewswire
Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
- Press releaseBusiness Wire
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
- NewsAvi Kapoor
Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings
- NewsAvi Kapoor
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of Shareholders
- NewsAvi Kapoor
US Stocks Mixed; Lowe's Cuts FY24 Forecast
- News
Market-Moving News for August 20th
- NewsAvi Kapoor
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
- Press releaseBusiness Wire
TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders
- Press releaseGlobe Newswire
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.